| human | Q5 |
| P2038 | ResearchGate profile ID | Jacob_George9 |
| P1153 | Scopus author ID | 57220841617 |
| P1416 | affiliation | Kaplan Medical Center | Q2890053 |
| P734 | family name | George | Q1260558 |
| George | Q1260558 | ||
| George | Q1260558 | ||
| P735 | given name | Jacob | Q25999604 |
| Jacob | Q25999604 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q73936011 | 'Autoantibody dominance' pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies |
| Q43753471 | 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice |
| Q33330951 | A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response |
| Q34354736 | Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome |
| Q73054106 | Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice |
| Q56901831 | Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes |
| Q51231358 | Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients. |
| Q71288357 | Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA |
| Q78000287 | Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic events |
| Q74238379 | Anti-endothelial cell antibodies in patients with coronary atherosclerosis |
| Q78053666 | Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty |
| Q36421852 | Anti-oxidized low-density lipoprotein antibodies in chronic heart failure |
| Q48419934 | Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure |
| Q46165765 | Antiphospholipid antibodies from a patient with primary antiphospholipid syndrome enhance experimental atherosclerosis |
| Q70867143 | Apoptosis and its association with autoimmunity |
| Q64389006 | Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLE |
| Q77344825 | Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus |
| Q34243799 | Atherosclerosis and autoimmunity |
| Q77549999 | Atherosclerosis and the antiphospholipid syndrome: a link unravelled? |
| Q73978602 | Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies |
| Q77794855 | Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis |
| Q47119794 | Atrial fibrillation and CHADS2 score as mortality predictors in young versus elderly patients undergoing coronary angiography |
| Q34157599 | Autoantibodies associated with atherosclerosis |
| Q57207033 | Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy |
| Q47182599 | Autoantibodies to oxidized low-density lipoprotein in patients with aortic regurgitation: association with aortic diameter size |
| Q33976585 | Autoimmunity in atherosclerosis. The role of autoantigens |
| Q33915478 | Autoimmunity in atherosclerosis: lessons from experimental models |
| Q48710431 | B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells |
| Q43183727 | Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure |
| Q33328443 | Beta2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels |
| Q34372303 | Beta2-glycoprotein I and atherosclerosis |
| Q74439056 | Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice |
| Q41017198 | Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA. |
| Q42544767 | Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression |
| Q36578461 | Circulating CD14(+) monocytes in patients with aortic stenosis |
| Q35935375 | Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic Stenosis |
| Q35772024 | Circulating adiponectin concentrations in patients with congestive heart failure |
| Q33370283 | Circulating apoptotic progenitor cells in patients with congestive heart failure |
| Q33778787 | Circulating autoantibodies to endothelial progenitor cells: binding characteristics and association with risk factors for atherosclerosis |
| Q35954189 | Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure |
| Q37269391 | Circulating endothelial progenitor cells in cardiovascular disorders |
| Q35954256 | Circulating endothelial progenitor cells in patients with cardiac syndrome X. |
| Q47360467 | Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation |
| Q46546835 | Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers |
| Q44316671 | Circulating progenitor and apoptotic progenitor cells in patients with aortic regurgitation |
| Q46073339 | Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice |
| Q34389649 | Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome |
| Q57134673 | Comparison of clinical and laboratory parameters for systemic lupus erythematosus activity in Israelis versus Europeans |
| Q40061808 | Constitutive expression of HIF-1alpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties |
| Q43625524 | Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies |
| Q34082315 | Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice |
| Q77862197 | Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model |
| Q74376610 | Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome |
| Q46825657 | Drug modification of angiogenesis in a rat cornea model |
| Q51555624 | Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. |
| Q55266680 | Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients. |
| Q73167881 | Elevated homocysteine levels in patients with Raynaud's syndrome |
| Q41298919 | Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis |
| Q36851576 | Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials |
| Q41936412 | Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. |
| Q74598447 | Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65 |
| Q77748422 | Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice |
| Q46690872 | Eptifibatide does not influence lymphocyte activation and CRP levels in patients with undergoing coronary angioplasty |
| Q47653074 | Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice |
| Q35462957 | Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling |
| Q40647691 | Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features. |
| Q58295565 | Functional T‐lymphocyte dichotomy in the peripheral blood of patients with unstable angina |
| Q44000690 | Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice |
| Q33503920 | Functional properties of antiendothelial cell antibodies |
| Q40988894 | Guillain-Barré as an autoimmune disease |
| Q51792819 | HIF-1alpha overexpression and experimental murine atherosclerosis. |
| Q46695151 | Hantavirus seropositivity in Israeli patients with renal failure |
| Q33495531 | Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome |
| Q74253684 | Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis |
| Q47788311 | Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis |
| Q44948359 | Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha |
| Q41000299 | Immune network and autoimmunity. |
| Q44430793 | Immunity to heat shock protein 65—an additional determinant in intimal thickening |
| Q73454535 | Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis |
| Q40957024 | Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression |
| Q73451856 | Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I |
| Q41500947 | Induction of autoimmunity. A role for the idiotypic network |
| Q77296598 | Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I |
| Q41517384 | Infections and Wegener's granulomatosis--a cause and effect relationship? |
| Q70905154 | Infections, idiotypes and SLE |
| Q33872000 | Inflammatory and immune aspects of atherosclerosis. |
| Q39663158 | Influence of Non-Toxic Doses of Bevacizumab and Ranibizumab on Endothelial Functions and Inhibition of Angiogenesis |
| Q44690056 | Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor |
| Q31123754 | Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice |
| Q73409234 | Interleukin (IL)-4 deficiency does not influence fatty streak formation in C57BL/6 mice |
| Q35546902 | Internal thoracic impedance - a useful method for expedient detection and convenient monitoring of pleural effusion |
| Q40765749 | Intravenous immunoglobulin treatment of lupus nephritis |
| Q43534849 | Ischemic hepatitis in congestive heart failure after an episode of hypotension |
| Q28513224 | Islet-1 gene delivery improves myocardial performance after experimental infarction |
| Q44890805 | L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty |
| Q73063639 | Lessons from the "Euro-Lupus Cohort" |
| Q71931778 | Leucocytoclastic vasculitis after coronary bypass artery grafting |
| Q54435972 | Low circulating monocyte count is associated with severe aortic valve stenosis. |
| Q77372010 | Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins |
| Q74522812 | Massive proteinuria as a main manifestation of primary antiphospholipid syndrome |
| Q33498624 | Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice |
| Q37786505 | Modified phospholipids as anti-inflammatory compounds |
| Q71683360 | Modulation of experimental systemic lupus erythematosus with linomide |
| Q42435697 | N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells |
| Q48474706 | Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy |
| Q43687605 | Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis |
| Q51798492 | Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. |
| Q33504372 | Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome |
| Q45086714 | Overexpression of 15-lipoxygenase in the vascular endothelium is associated with increased thymic apoptosis in LDL receptor-deficient mice |
| Q74290882 | Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice |
| Q33499323 | Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS). |
| Q64050030 | Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon |
| Q71120643 | Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model |
| Q48184152 | Predictive value of high sensitivity CRP in patients with diastolic heart failure |
| Q53368605 | Pregnancy and antiphospholipid syndrome. A report and relevant abstracts from the 4th International Conference on Systemic Lupus Erythematosis, Jerusalem, March 1995. |
| Q41923411 | Preventive treatment of alveolar pulmonary edema of cardiogenic origin |
| Q40643668 | Q fever endocarditis and bicuspid aortic valve |
| Q46019889 | Ras inhibition attenuates myocardial ischemia-reperfusion injury. |
| Q39685031 | Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: possible role of regulatory T cells |
| Q39398353 | Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes |
| Q45968566 | Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice. |
| Q33955305 | Ras inhibition induces insulin sensitivity and glucose uptake |
| Q31401742 | Reactivity of peripheral blood lymphocytes to oxidized low-density lipoprotein: a novel system to estimate atherosclerosis employing the Cellscan |
| Q35195128 | Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner |
| Q37739367 | Regulatory T-cells, FoxP3 and atherosclerosis. |
| Q44491239 | Relation of preexisting anti-beta2GPI antibodies to infarct size in a rat model |
| Q52539711 | Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. |
| Q44647010 | Safety of Nitrate Withdrawal in Angina-Free and Hemodynamically Stable Patients With Coronary Artery Disease * |
| Q78095704 | Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin |
| Q58088703 | Serum levels of anti heat shock protein 70 antibodies in patients with stable and unstable angina pectoris |
| Q44403581 | Severe Blastocystis hominis in an elderly man. |
| Q40493907 | Shortness of Breath During Pregnancy: Could a Cardiac Factor Be Involved? |
| Q41331719 | Smoking and immunity: an additional player in the mosaic of autoimmunity |
| Q28191086 | Stent thrombosis in patients treated with thienopyridines: clinical description of 10 cases |
| Q50940124 | Stroke volume adjusted to afterload for assessment of cardiac performance in patients with severe aortic stenosis and preserved left ventricular ejection fraction. |
| Q74142983 | Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents |
| Q47442034 | Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. |
| Q47312074 | Suppression of myosin-induced and adoptively transferred myocarditis by prior treatment with complete Freund's adjuvant |
| Q36399103 | Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". |
| Q74477243 | Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding |
| Q34591260 | The 106b∼25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice |
| Q73469005 | The Effect of Agmatine on Ischemic and Nonischemic Isolated Rat Heart |
| Q46162748 | The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat. |
| Q73710370 | The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis |
| Q38249659 | The current status of transcutaneous aortic valve implantation |
| Q44882872 | The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis |
| Q77104415 | The effect of intravenous immunoglobulins on intimal thickening in a mouse model of arterial injury |
| Q74362762 | The effect of intravenous immunoglobulins on the progression of experimental autoimmune myocarditis in the rat |
| Q42478982 | The effect of tyrphostin AG-556 on intimal thickening in a mouse model of arterial injury |
| Q73901886 | The effects of N-6 polyunsaturated fatty acid supplementation on the lipid composition and atherogenesis in mouse models of atherosclerosis |
| Q41152545 | The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus |
| Q40911566 | The emerging concept of pathogenic natural autoantibodies. |
| Q40677639 | The hantaviruses--clinical syndromes |
| Q78108902 | The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis |
| Q54672449 | The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. |
| Q71821076 | The occurrence of thromboembolic events following airplane flights--'the economy class syndrome' |
| Q37876166 | The prediction of coronary atherosclerosis employing artificial neural networks |
| Q36352011 | The role of erythropoietin in myocardial protection: potential mechanisms and applications |
| Q53085817 | Thoracic aortic atherosclerosis in patients with aortic regurgitation. |
| Q47366903 | Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice |
| Q44462507 | Tyrphostin AG-556 reduces myocardial infarct size and improves cardiac performance in the rat. |
| Q73187708 | Use of intravenous immunoglobulin in idiopathic membranous nephropathy |
| Q40537727 | Usefulness of Antibodies to Oxidized Low-Density Lipoproteins as Predictors of Morbidity and Prognosis in Heart Failure Patients Aged ≥65 Years |
| Q48797914 | Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure. |
| Q40598045 | Whole body hyperthermia accelerates atherogenesis in low-density lipoprotein receptor deficient mice |
| Q44985119 | Zinc reduces intimal hyperplasia in the rat carotid injury model |
| Q70869512 | [Apoptosis (programmed cell death) in autoimmunity--autoimmunological aspect] |
| Q70869445 | [Atherosclerosis as an immune process] |
| Q71940915 | [Cellular immune responses in rheumatic fever] |
| Q71257352 | [Fungi and autoimmune conditions] |
| Q74064819 | [Hyperhomocysteinemia--a risk factor or vascular disease?] |
| Q71627643 | [Mixed connective tissue disease -- thirty three years of uncertainty] |
| Q74126903 | [Primary subclavian vein thrombosis after intensive physical exertion] |
Search more.